18FDG PET/CT imaging of the pancreas: Spectrum of diseases

Vien X. Nguyen, Cuong C Nguyen, Ba D. Nguyen

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Since the introduction of integrated positron emission tomography-computed tomography (PET/CT), it has a great impact on the field of oncology. Comparing to other conventional scanners, only PET/CT is capable of providing important information on accurate detecting, staging/restaging, and post-therapeutic monitoring of many cancers. Many studies have demonstrated that PET/CT changes the management in approximately 30% of all cancer patients. Because 2-(18F)-fluoro-2-deoxy-D-glucose (FDG) is a nonspecific tracer, understanding the PET/CT limitations and pitfalls for various pancreatic conditions can lead to more accurate interpretation of PET/CT images, which ultimately would impact patient care. As a result, it is important for radiologists and other clinicians to familiarize themselves with a wide spectrum of pancreatic PET/CT findings simulating cancer from benign entities.

Original languageEnglish (US)
Pages (from-to)557-566
Number of pages10
JournalJournal of the Pancreas
Volume12
Issue number6
StatePublished - Nov 2011

Fingerprint

Fluorodeoxyglucose F18
Pancreas
Neoplasms
Positron Emission Tomography Computed Tomography
Patient Care

Keywords

  • Fluorodeoxyglucose F18
  • Neoplasm metastasis
  • Pancreas
  • Pancreatic neoplasms
  • Positron-emission tomography;tomography
  • X-ray computed

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Medicine(all)

Cite this

18FDG PET/CT imaging of the pancreas : Spectrum of diseases. / Nguyen, Vien X.; Nguyen, Cuong C; Nguyen, Ba D.

In: Journal of the Pancreas, Vol. 12, No. 6, 11.2011, p. 557-566.

Research output: Contribution to journalArticle

Nguyen, VX, Nguyen, CC & Nguyen, BD 2011, '18FDG PET/CT imaging of the pancreas: Spectrum of diseases', Journal of the Pancreas, vol. 12, no. 6, pp. 557-566.
Nguyen, Vien X. ; Nguyen, Cuong C ; Nguyen, Ba D. / 18FDG PET/CT imaging of the pancreas : Spectrum of diseases. In: Journal of the Pancreas. 2011 ; Vol. 12, No. 6. pp. 557-566.
@article{bdde7dc84dfd4746bca8ea0ab8144345,
title = "18FDG PET/CT imaging of the pancreas: Spectrum of diseases",
abstract = "Since the introduction of integrated positron emission tomography-computed tomography (PET/CT), it has a great impact on the field of oncology. Comparing to other conventional scanners, only PET/CT is capable of providing important information on accurate detecting, staging/restaging, and post-therapeutic monitoring of many cancers. Many studies have demonstrated that PET/CT changes the management in approximately 30{\%} of all cancer patients. Because 2-(18F)-fluoro-2-deoxy-D-glucose (FDG) is a nonspecific tracer, understanding the PET/CT limitations and pitfalls for various pancreatic conditions can lead to more accurate interpretation of PET/CT images, which ultimately would impact patient care. As a result, it is important for radiologists and other clinicians to familiarize themselves with a wide spectrum of pancreatic PET/CT findings simulating cancer from benign entities.",
keywords = "Fluorodeoxyglucose F18, Neoplasm metastasis, Pancreas, Pancreatic neoplasms, Positron-emission tomography;tomography, X-ray computed",
author = "Nguyen, {Vien X.} and Nguyen, {Cuong C} and Nguyen, {Ba D.}",
year = "2011",
month = "11",
language = "English (US)",
volume = "12",
pages = "557--566",
journal = "Journal of the Pancreas",
issn = "1590-8577",
publisher = "E.S. Burioni Ricerche Bibliografiche",
number = "6",

}

TY - JOUR

T1 - 18FDG PET/CT imaging of the pancreas

T2 - Spectrum of diseases

AU - Nguyen, Vien X.

AU - Nguyen, Cuong C

AU - Nguyen, Ba D.

PY - 2011/11

Y1 - 2011/11

N2 - Since the introduction of integrated positron emission tomography-computed tomography (PET/CT), it has a great impact on the field of oncology. Comparing to other conventional scanners, only PET/CT is capable of providing important information on accurate detecting, staging/restaging, and post-therapeutic monitoring of many cancers. Many studies have demonstrated that PET/CT changes the management in approximately 30% of all cancer patients. Because 2-(18F)-fluoro-2-deoxy-D-glucose (FDG) is a nonspecific tracer, understanding the PET/CT limitations and pitfalls for various pancreatic conditions can lead to more accurate interpretation of PET/CT images, which ultimately would impact patient care. As a result, it is important for radiologists and other clinicians to familiarize themselves with a wide spectrum of pancreatic PET/CT findings simulating cancer from benign entities.

AB - Since the introduction of integrated positron emission tomography-computed tomography (PET/CT), it has a great impact on the field of oncology. Comparing to other conventional scanners, only PET/CT is capable of providing important information on accurate detecting, staging/restaging, and post-therapeutic monitoring of many cancers. Many studies have demonstrated that PET/CT changes the management in approximately 30% of all cancer patients. Because 2-(18F)-fluoro-2-deoxy-D-glucose (FDG) is a nonspecific tracer, understanding the PET/CT limitations and pitfalls for various pancreatic conditions can lead to more accurate interpretation of PET/CT images, which ultimately would impact patient care. As a result, it is important for radiologists and other clinicians to familiarize themselves with a wide spectrum of pancreatic PET/CT findings simulating cancer from benign entities.

KW - Fluorodeoxyglucose F18

KW - Neoplasm metastasis

KW - Pancreas

KW - Pancreatic neoplasms

KW - Positron-emission tomography;tomography

KW - X-ray computed

UR - http://www.scopus.com/inward/record.url?scp=80855141546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80855141546&partnerID=8YFLogxK

M3 - Article

C2 - 22072244

AN - SCOPUS:80855141546

VL - 12

SP - 557

EP - 566

JO - Journal of the Pancreas

JF - Journal of the Pancreas

SN - 1590-8577

IS - 6

ER -